Next Article in Journal
Putative RNA Ligase RtcB Affects the Switch between T6SS and T3SS in Pseudomonas aeruginosa
Next Article in Special Issue
Possible Treatment of Myocardial Infarct Based on Tissue Engineering Using a Cellularized Solid Collagen Scaffold Functionalized with Arg-Glyc-Asp (RGD) Peptide
Previous Article in Journal
ML218 HCl Is More Efficient Than Capsaicin in Inhibiting Bacterial Antigen-Induced Cal 27 Oral Cancer Cell Proliferation
Previous Article in Special Issue
Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Green Synthesis of Silver Nanoparticles Using Olea europaea Leaf Extract for Their Enhanced Antibacterial, Antioxidant, Cytotoxic and Biocompatibility Applications

1
Laboratory of Treatment and Valorization of Water Rejects, Water Research and Technologies Center (CERTE), Borj-Cedria Technopark, University of Carthage, Soliman 8020, Tunisia
2
Center of Super-Diamond and Advanced Films (COSDAF), Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong 999077, China
3
Department of Physics, The University of Hong Kong, Hong Kong 999077, China
4
Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(22), 12562; https://doi.org/10.3390/ijms222212562
Submission received: 12 November 2021 / Revised: 20 November 2021 / Accepted: 21 November 2021 / Published: 22 November 2021
(This article belongs to the Collection Feature Papers in Materials Science)

Abstract

:
Herein, we report the green synthesis of silver nanoparticles (OE-Ag NPs) by ecofriendly green processes using biological molecules of Olea europaea leaf extract. Green synthesized OE-Ag NPs were successfully characterized using different spectroscopic techniques. Antibacterial activity of OE-Ag NPs was assessed against four different bacteriological strains using the dilution serial method. The cytotoxic potential was determined against MCF-7 carcinoma cells using MTT assay in terms of cell viability percentage. Antioxidant properties were evaluated in terms of 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging. Biocompatibility was further examined by incubating the synthesized NPs with hMSC cells for 24 h. The results were demonstrated that synthesized OE-Ag NPs presented excellent log10 reduction in the growth of all the tested bacterial strains, which as statistically equivalent (p > 0.05) to the standard antibiotic drug. Moreover, they also demonstrated excellent cytotoxic efficacy against the MCF-7 carcinoma cells compared to plant lead extract and Com-Ag NPs. Green synthesized OE-Ag NPs appeared more biocompatible to hMSC and 293T cells compared to Com-Ag NPs. Excellent biological results of the OE-Ag NPs might be attributed to the synergetic effect of NPs’ properties and the adsorbed secondary metabolites of plant leaf extract. Hence, this study suggests that synthesized OE-Ag NPs can be a potential contender for their various biological and nutraceutical applications. Moreover, this study will open a new avenue to produce biocompatible nanoparticles with additional biological functionalities from the plants.

1. Introduction

The emergence of drug resistance in different bacteria has become a significant public health problem. Currently, antibiotics have been used as an effective treatment against bacterial exposure owing to their satisfactory outcomes. However, their great use without maintaining prescription policies leads to increased antibiotic resistance in bacteria. Hence, multi-drug resistant (MDR) bacteria were defined as bacteria that acquired resistance to at least one antibiotic from three or more classes of antibiotics and are frequently responsible for infection associated with healthcare settings [1]. Moreover, an infection caused by MDR bacteria has become significantly challenging, especially in developing countries, and has been associated with high morbidity and mortality rates [2]. In addition, it has been estimated that infections by resistant bacteria may rise to 10 million death/year by 2050 more than any other causes and like the most global issues [3]. Therefore, the challenge of antibiotic resistance is becoming alarming, and the development of new alternatives antibacterial agents to combat has become an urgent need. Recently, nanotechnology has provided many multi-disciplinary research concepts in the scientific area, which can overcome this challenging situation [4]. This technology has led to the design and fabrication of nanomaterials and nanoparticles with exceptionally high surface area to volume ratio and small size, which determines their physical, chemical, mechanical, optical, electrical, solubility, and stability. Generally, several physical and chemical methods have been intensively used for synthesizing nanoparticles. However, these methods generally involve using a toxic solvent that would pollute the environment and strictly limit the use of NPs in scientific and technical fields. Hence, it is imperative to develop economic alternative processes for nanomaterials synthesizing for future biological applications [5]. Notably, in recent years, nanobiotechnology has been established as a new branch of nanotechnology. This technology combines biological systems with physical and chemical procedures to produce nano-sized particles with specific functions [6]. Hence, biological synthesis or ‘green’ synthesis of NPs has attracted significant attention due to their cost-effective, environmentally friendly, and resulting biocompatible nanoparticles [7]. Many naturally biological sources, including fungi, bacteria, plants, and algae, have been employed in the biosynthesis of nanoparticles. Although compared to other naturally available biological sources, plants have attracted much attention, and they are more suitable for the biosynthesis of NPs owing to their high stability, easily scalable, readily available, and no particular storage condition required. In typical NPs biosynthesis, plant extracts were used as reducing and stabilizing agents.
Moreover, these extracts are mainly composed of numerous secondary metabolites, such as sugars, polyphenols, flavonoids, and terpenoids. Their oxidation induces the reduction of metal ions and the formation of metallic NPs. Among the different metallic NPs, silver nanoparticles (Ag NPs) have been extensively explored for their exclusive properties (e.g., size and shape depending optical, electrical, and magnetic properties) [8,9,10]. On the other hand, Ag NPs have been shown to exhibit chemical stability, good conductivity, antibacterial and catalytic activities, as well as a cytotoxic effect on cancer cells [11]. In this regard, phytochemicals and secondary metabolites present in plant extracts can cap and reduce Ag+ ions to Ag0 [12]. Therefore, it is suitable for the large-scale synthesis of Ag NPs in a non-aseptic environment.
In this work, we have synthesized Ag NPs using biological molecules of leaf extract of Olea europaea L. Olea europaea L. belongs to the Oleaceae family, is one of the essential fruit trees widely cultivated in the Mediterranean region (approximately 98% of the world crop) [13]. Olive leaves are agricultural by-products that have attracted growing interest in the scientific and industrial community due to their health benefits and nutritional effects [14]. Hence, Olea europaea leaves were considered promising sources of bioactive compounds, mainly phenolic compounds. The major abundant compounds are Oleuropein and Hydroxytyrosol and other flavonoids, such as Apigenin-7-glucoside, Luteolin-7-glucoside, and Verbascoside [15,16]. The isolated bioactive compounds have been found to have antiviral [17], antimicrobial [18], antioxidant [19], anti-inflammatory [20], anticancer [16], antihypertensive [21] and hypoglycemic properties [22]. Thus, in the present research, Ag NPs were synthesized using Olea europaea phytomolecules as a reducing and stabilizing agent. The green synthesized OE-Ag NPs were further evaluated for their different applications, i.e., antioxidant, antibacterial, and anticancer.

2. Results and Discussion

2.1. Characterization

Olea europaea is a rich source of different biological important secondary metabolites that can be used for the synthesis of biogenic nanoparticles as reducing and capping agents [23,24]. Therefore, we have employed the leaf extract of this plant as reducing and capping agents for the synthesis of biogenic silver nanoparticles. Figure 1a presents the possible mechanism for the synthesis of OE-Ag NPs using the plant leaf extract. Polyphenols and flavonoids present in the leaf extract might be involved in reducing the silver ions to metallic form following the redox reaction. Simultaneously, other secondary metabolites such as alkaloids, terpenoids, saponins present in the leaf extract might readily be stabilized the formed Ag0 by capping and finally converted into silver nanoparticles (OE-Ag NPs). Similar synthesis mechanism was also reported by Hussain et al. [25].
The chemical reaction between the dissolved silver ions and plant leaf extract was examined with a UV-Visible spectrophotometer. UV-Visible analysis revealed that upon reaction completion and formation of OE-Ag NPs, an absorption peak at 410 nm was observed due to the surface plasmon resonance phenomenon (Figure 1b) [26]. An additional absorption peak at 310 nm was also observed, which might be due to the adsorbed polyphenols. Literature shows that polyphenols usually produce UV-Visible absorption peaks in the ultra-violet region due to the presence of hydroxyl moieties [27,28,29,30]. On the other hand, plant leaf extract shows two UV-Visible absorption peaks (255 nm and 290 nm) in the ultraviolet region (Figure 1c). A slight blue shift in UV-Visible absorption peaks of plant leaf extract was observed compared to the reported by [31]. This might be attributed to the different phytomolecules present in the leaf extract which depends on the nature of soil and environments in which plant is grow.
FTIR analysis of both plant leaf extract and OE-Ag NPs was carried out further, and their spectra are shown in Figure 1d. FTIR spectra of plant leaf extract showing different IR peaks at 3400 cm−1 (-OH), 2920–2880 cm−1 (C-H), 1706 cm−1 (C=O), 1630 cm−1 (aromatic C=C), and several others [31] which indicates the presence of several phytomolecules. On the other hand, OE-Ag NPs are also presented a similar pattern of FTIR peaks with slight shifts in wavenumbers and intensity. Hence, FTIR results corroborated that green synthesized OE-Ag NPs are successfully capped and stabilized with the plant leaf extract’s secondary metabolites.
Further, the green synthesized OE-Ag NPs were characterized with XRD. XRD diffraction pattern indicates the sharp, narrow, and intense peaks corroborating the highly crystalline nature of the synthesized NPs (Figure 2a). Four diffraction peaks at 38.60, 44.56, 64.65, and 77.65 were observed, which correspond to crystal planes (111), (200), (220), and (311) respectively [32]. Figure 2b shows the TEM image of the green synthesized OE-Ag NPs. TEM analysis displays that the synthesized NPs are spherical in morphology with uniform distribution. TEM analysis shows that the average size of NPs is 8 nm (5 to 14 nm particle size range) (Figure 2c). Figure 2d shows the compositional analysis results carried out with EDX. EDX confirms that the synthesized NPs are mainly composed of silver. Besides, the spectra also show different EDX peaks associated with oxygen, nitrogen, and carbon. These peaks might be attributed to the surface adsorbed phytomolecules (alkaloids, polyphenols, flavonoids, etc.) from the plant leaf extract during capping. A consistency was observed in the results of FTIR and EDX analysis. Hence all characterization results confirm the successful fabrication of our desired nanoparticles.

2.2. Antibacterial Activity

Antibacterial activity of green synthesized OE-Ag NPs was assessed against Gram-positive and Gram-negative bacterial strains. The results demonstrated the highest antibacterial activity in terms of log10 reductions in bacterial growth with green synthesized OE-Ag NPs compared to a plant extract and Com-Ag NPs (Figure 3). Interestingly, the antibacterial activity presented by green synthesized OE-Ag NPs was comparable (p > 0.05) to the standard antibiotic drug. Moreover, plant leaves extract also displayed good antibacterial activity against all the microbial strains. The enhanced antibacterial activity of OE-Ag NPs might be due to the synergistic effect of NPs’s physical properties and adsorbed secondary metabolites on their surface from the plant extract, as evident from the results of FTIR and EDX analysis. A similar finding was also reported by [27,28,30,33,34,35,36].
It has been observed that green synthesized OE-Ag NPs exhibited more efficiency in killing the Gram-negative bacterial strains than that of Gram-positive bacterial strains. This might be attributed to their easy penetration and more electrostatic attraction with surface bounds functional moieties (e.g., sulfur proteins) of the cell wall and cytoplasmic membrane of the Gram-negative bacterial strains compared to Gram-positive. The easy penetration of green synthesized OE-Ag NPs might have occurred because Gram-negative bacterial strains have thinner cell wall than Gram-positive (Figure 4) [37,38]. Moreover, both Gram-positive and Gram-negative bacteria differ in the structure and composition of their cell walls [39] as shown in Figure 4. The cell wall of Gram-positive bacteria comprises of multilayer channels of thick peptidoglycan, lipoteichoic acid and wall teichoic acid. Both lipoteichoic acid and wall teichoic acid are attached to peptidoglycan as well as cell membrane. On the other hand, Gram-negative bacteria cell wall consists of outer/inner membrane layers, thin layer of peptidoglycan, lipopolysaccharides, and gel like periplasm. The lipopolysaccharides are highly negatively charged macromolecules that are only present in outer membrane layers of Gram-negative bacterial strains [38,39].

Antibacterial Mechanism

The antibacterial mechanism of the green synthesized OE-Ag NPs was evaluated further with Live and dead staining assay. Live/dead stating assay was carried out against three bacteria (S. aureus, K. pneumonia, and P. aeruginosa) using a double staining kit (Hoechst 33,342 /PI). Both dyes are used for the differentiation of the live and dead bacteria cells. Hoechst 33,342 is a permanent membrane dye and can stain both live/dead cells upon intercalation with DNA [40]. On the other hand, PI is an impermeant membrane dye that can only penetrate bacteria cells when the cell membrane has been destroyed. Therefore, PI is used for the staining of dead cells. Figure 5 shows that untreated bacterial strains only stained with Hoechst 33,342, indicating that the bacteria cells live, and their cell membrane is intact. On the other hand, treated bacteria demonstrated red fluorescence displaying that their cell membrane has been destroyed by the action of green synthesized OE-Ag NPs. These results revealed that one possible reason behind the antibacterial action of green synthesized OE-Ag NPs is the disruption of bacteria cell membrane integrity.
After confirmation of bacterial cell deaths by physical damage of their cell membrane with the green synthesized OE-Ag NPs, we further hypothesized that bacterial cell death might also be induced by the oxidative stress produced by the reactive oxygen species (ROS) such as hydroxyl radicals OH, superoxide ions O2–•, H2O2, and hydroperoxyl radicals [40]. It has been reported that Ag-based materials and nanoparticles have the ability to generate ROS upon interaction with microbial cells [41,42,43]. To get more insight into the antibacterial mechanism of the green synthesized OE-Ag NPs, we further performed an intracellular ROS measuring experiment using CellROX®Green staining kit. Figure 6 displayed that no intracellular ROS generation has been taken place in untreated bacteria. However, maximum ROS generation has been observed in all tested bacteria treated with H2O2. Similar ROS intracellular generation has also experimented with all bacteria treated with green synthesized OE-Ag NPs. These findings further corroborated that the bacteria cell death also resulted from oxidative stress produced by the green synthesized OE-Ag NPs.
After examining the rupture of cell membrane integrity and the generation of intracellular oxidative stress caused by ROS species, we can suggest a mechanism for Bacterial cell death caused by green produced OE-Ag NPs. As a consequence, the OE-Ag NPs exhibited superior antibacterial activity as a result of physical and oxidative degradation, which resulted in the production of various intracellular alterations. (1) The interaction of OE-Ag NPs with cell membrane proteins and other biomacromolecules such as lipopolysaccharides, etc., results in the breakdown of the cell membrane. (2) Disintegration of the cell membrane increased the membrane’s permeability for nanoparticle penetration. (3) Membrane permeabilization may also be triggered the leakage of intracellular function. (4) Following their penetration, the OE-Ag NPs may interact with various cellular organelles, causing oxidative stress and further impairing their physiological activities. All of these factors may contribute to the OE-Ag NPs’ ability to kill Gram-positive and Gram-negative bacteria.

2.3. Antioxidant Potential

The green synthesized OE-Ag NPs’ antioxidant potential was evaluated in terms of DPPH free radical scavenging compared to plant leaves extract, Com-Ag NPs, and standard ascorbic acid. The results were displayed the maximum antioxidant activity with green synthesized OE-Ag NPs compared to plant extract and Com-Ag NPs, however comparable to standard ascorbic acid (Figure 7). On the other hand, plant leaf extract significantly scavenged the DPPH free radical and presented good antioxidant potential compared to Com-Ag NPs. The good antioxidant activity of the plant leaves extract might be attributed to the presence of electron-rich secondary metabolites such as phenolics, flavonoids, etc., [44,45,46,47]. Secondary metabolites such as phenolics and flavonoids are well-acknowledged to present antioxidant properties [48,49,50]. In the case of OE-Ag NPs, their enhanced DPPH scavenging ability compared to Com-Ag NPs might also be due to the presence of these secondary metabolites on their surface. Similar findings of enhanced antioxidant activity upon adsorption of these secondary metabolites on the surface of green synthesized NPs and upon metal chelation with phytomolecules compared to alone metal-ligand were also reported by [51,52,53,54,55].

2.4. Cytotoxic Propensity

The cytotoxicity propensity of the green synthesized OE-Ag NPs was determined in terms of cell viability percentage of MCF-7 carcinoma cell lines using MTT assay compared to plant extract and Com-Ag NPs. Findings exhibit that the superior cytotoxic effect was induced by the green synthesized OE-Ag NPs than both plant leaf extract and Com-Ag NPs (Figure 8a). On the other hand, Com-Ag NPs presented more cytotoxic efficacy against the MCF-7 carcinoma cells compared to plant leaf extract. It was worthy to note that plant leaf extract also demonstrated good killing efficacy against MCF-7 cells which can be attributed to the presence of cancer killing secondary metabolites (polyphenols, flavonoids, alkaloids, terpenoids, saponins, etc.) [56,57]. On the other hand, enhanced cytotoxic propensity of OE-Ag NPs compared to Com-Ag NPs might be due to the presence of biological active secondary metabolites of plant leaf extract on their surface. Mona et al. has also reported the similar enhanced cytotoxic efficacy of biogenic silver nanoparticles synthesized by lichens [26].

2.5. Biocompatibility Analysis

Biocompatibility of the nanoparticles is the utmost desire for their application in biological system. Therefore, we further evaluated synthesized OE-Ag NPs for their biocompatibility with normal cell line hMSC using MTT assay compared to plant leaf extract and Com-Ag NPs. The results are presented in Figure 8b. Results were demonstrated that plant leaf extract displayed excellent biocompatibility presenting superior cell viability percentage (85.51%). While green synthesized OE-Ag NPs exhibited good biocompatibility with hMSC cell lines and shown 78.66% cell viability percentage. On the other hand, least biocompatibility was shown by the Com-Ag NPs.
Using the live/dead staining approach, we further evaluated the cytobiocompatibility of the OE-Ag NPs with 293T cell line in comparison to the plant leaf extract Com-Ag NPS. Figure 9a–d illustrates the findings. The results revealed that plant leaf extract and OE-Ag NPs had the least detrimental impact on 293T cells, resulting in fewer cells dying. In comparison, chemically generated Com-Ag NPs were more lethal, and a significant number of cells seemed to be perished (Red). The enhanced cytobiocompatibility of green synthesized OE-Ag NPs with hMSC cells and 293T cells might be resulted because of the existence of biological active and biocompatible secondary metabolites of the plant leaf extract. The similar finding on the biocompatible nature of plant leaf extract and enhanced cytobiocompatibility of the nanoparticles after the inclusion of secondary metabolites on their surface were also reported by [58,59].

3. Materials and Methods

3.1. Chemicals and Collection of Plant Materials

Analytical grade chemicals and chemically synthesized silver nanoparticles (Com-Ag NPs) were purchased from Sigma-Aldrich. Experiments were carried out on leaves of the Chetoui cultivar of Olea europaea L., cultivated in Borj El Amri in the North of Tunisia. Fresh green leaves were collected until the end of olive morphology (February 2019). Olea europaea leaves were identified and authenticated by Professor Fathi Ben Amar at the olive institute of Sfax, Tunisia.

3.2. Plant Extract Preparation and OE-Ag NPs Synthesis

Fresh leaves of Olea europaea were washed with deionized water (DI) to remove dust particles, plankton, and insects, and then dried under shady at room temperature (25–30 °C). The dried leaves were milled into powder using a commercial grinder. The plant leaves powder was stored in glass bottles for future use. The preparation of plant extract and synthesis of OE-Ag NPs was carried out following the procedure reported by [30]. Ten g of the ground leaves powder of Olea europaea was added to 100 mL of DI water. Then, the aqueous mixture was heated to boil with rigorous stirring for 5 min. The boiled mixture was filtered with filter paper to get a yellowish-colored extract. Then, the leaves extract was used as a reducing and capping agent to convert silver salt to its metallic form. A total of 1 mM of AgNO3 was added to 25 mL of leaves extract of Olea europaea. Afterward, the mixture was heated at 80 °C for 65 min with constant stirring to obtain a dark brown dispersion of OE-Ag NPs. After centrifugation for 15 min at 15,000 rpm, the obtained OE-Ag NPs were washed with DI water three times and dried in an oven at 70 °C.

3.3. Characterization of OE-Ag NPs

The green synthesis OE-Ag NPs were characterized using different spectroscopic techniques. X-ray Diffraction (XRD) was performed using Bruker D2 PHASER with LYNXEYE XE-T detector diffractometer (Haidian, Beijing, China) operating at 40 kV and 30 mA with Cu Kα radiation (k =1.54056 A°) to test the crystallinity and purity of OE-Ag NPs. Energy-dispersive X-ray spectroscopy using Thermo Fisher Scientific Ultradry (Madison, WI, USA) was performed to determine the elemental composition of the green-synthesized OE-Ag NPs. A transmission electron microscope (TEM) (Jeol, 5910 LV, Tokyo, Japan) was carried out to determine the morphology of the synthesized Ag NPs. Fourier Transform Infra-Red spectra (FTIR) (Bruker, Germany. Model: Vertex 70) analysis was performed to determine whether phytomolecules of plant leaves extract were involved or not in the green synthesis of OE-Ag NPs. UV–visible analysis was carried out using a spectrophotometer (Shimadzu 1700, Columbia, MD, USA).

3.4. Antioxidant Activity

Antioxidant activity of the green synthesis OE-Ag NPs was determined by using a DPPH free radical scavenging assay [5]. In a typical experiment, DPPH solution (0.1 mM) in ethanol was mixed with different concentrations (500 µg/mL) of each sample (OE-Ag NPs, plant extract, Com-Ag NPs, and standard) that were prepared separately. Then, the reaction mixtures were stirred for 10 min and kept in the dark at room temperature for 1 h. After incubation, the absorbance was measured with a UV-Visible spectrophotometer at 517 nm. The percentage scavenging activity was calculated using the following formula:
% DPPH free radical scavenging = [(Ab − As)/Ab] × 100,
where As is the absorbance of the sample and Ab is the blank absorbance (only DPPH solution).

3.5. Antibacterial Activity

The synthesized OE-Ag NPs were scrutinized for their antibacterial activity against two Gram-negative bacterial strains [Pseudomonas aeruginosa (ATCC®27853TM) and Klebsiella pneumonia (ATCC® 13,883)] and two Gram-positive bacterial strains [Staphylococcus aureus (ATCC® 15,564) and Bacillus subtilis (ATCC® 6051)] using the serial dilution method as described by [60]. In general, the strains of bacteria (5 × 105 CFU/mL) were seeded onto separate blood agar plates and then cultured for 24 h at 37 °C. After several bacterium colonies were grown on the plates, they were diluted with phosphate buffer saline (PBS). Their cell density was maintained to 1 × 107 colony forming units (CFU) per mL. Following that, 10 µL of each bacterial culture was separately added to the wells of a 24-well microtiter plate with 1.0 mL of Mueller–Hinton broth (MHB). For each well, the final concentration of each bacterium was 1 × 105 CFU/mL. A 50 µL of each sample solution at 250 µg/mL concentration was then transferred to separate wells and incubated at 37 °C for 24 h. The bacterial species were then counted in the wells using the serial dilution plate counting method. The antibacterial propensity was expressed in the form of log10 reduction in bacterial growth using the following formula:
Log10 reduction = log10 (CFUBI) − log10 (CFUAI),
where CFUBI and CFUAI are the CFU of bacterial strains before and after 24 h of incubation, respectively, with the treatment of sample solutions. Standard antibiotic drug used in this study was Cefradine.

3.6. Live/Dead Bacterial Staining Assay

Live and dead bacterial staining assay was carried out using a confocal laser scanning microscope (CLSM, FV-1200, Olympus, Tokyo, Japan) to confirm the antibacterial activity of green synthesized OE-Ag NPs. The assay was performed following the methods reported by Choi et al. [61]. Briefly, two nucleic dyes, Hoechst 33,342 (membrane-permeant) and propidium iodide (PI; membrane-impermeant), were used for staining the live (green) and dead (red) bacteria, respectively. Each bacterium was cultured in nutrient broth in an orbital shaker for 24 h at 37 °C to reach the stationary phase, which was consists of approximately 105–106 colony forming units (CFU) per ml. After incubation, each bacteria strain was inoculated into sterilized cover glass coated with poly-L-lysine in a 24-well plate and then incubated for 1 h for bacterial cells attached to the cover glass. The suspended bacterial cells were then discarded, and each cover glass was gently rinsed three times with a saline solution. For the treatment, each bacterium cells on the cover glass were incubated with green synthesized OE-Ag NPs (250 μg/mL) and then incubated for 24 h at 37 °C. Bacteria cells on cover glass were then stained with an alive and dead bacterial viability kit in accordance with the manufacturer’s recommendations. Dead and live bacterial cells were analyzed with CLSM using an excitation wavelength of 493 nm and 350 nm for PI and Hoechst 33,342 and an emission wavelength of 636 nm and 461 nm for PI and Hoechst 33,342, respectively. We only considered green synthesized OE-Ag NPs for live/dead staining assay as they presented excellent antibacterial properties in terms of Log10 reductions.

3.7. Intracellular ROS Generation Investigations

The CellROX®Green staining was further used to examine the death of bacterial species caused by intracellular ROS production. In brief, bacterial species (Staphylococcus aureus and Pseudomonas aeruginosa) at 1 × 107 CFU/mL with 70 μL of produced OE-Ag NPs at a concentration of 250 μg/mL and incubating at 37 °C for 24 h. Following that, the microbial cells were treated for an additional 30 min at 37 °C with CellROX®Green (5 μm). Following that, CLSM was utilized to acquire CLSM images at 485 nm absorption and 520 nm emission wavelengths. To assess microbial cells’ ability to generate reactive oxygen species (ROS), the results of cells treated with NPs were compared to those treated with 1 mm H2O2 (positive control) and untreated cells (negative control).

3.8. Anticancer Activity

The OE-Ag NPs were tested for their anticancer activity against MCF-7 (breast cancer cells) by MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) colorimetric assay [30]. The MCF-7 carcinomatous cells were kept in Dulbecco’s Modified Eagle’s Medium (DMEM) in a humidified atmosphere comprising 5% CO2 and 95% air at 37 °C. To get the cell confluency (5 × 108 cells/well), MCF-7 cells were cultured in a 96-microtiter plate containing 100 µL of DMEM for 24 h at 37 °C in 5% CO2. Different concentrations (1, 5, 10, 15, 30, 60, and 120 µg/mL) of green synthesized OE-Ag NPs were prepared in cell culture media and then mixed with cancer cells, and the plate was further incubated for 24 h at 37 °C. Cells without OE-Ag NPs were served as a negative control, and cells with the standard drug (doxorubicin) were served as a positive control. Afterward, the plate was centrifuged to remove the supernatant and subsequently washed with phosphate buffer saline solution. A total of 15 µL of MTT reagent at the concentration of 0.5 mg/mL was added to each well, and the plate was then incubated for 4 h at 37 °C. After incubation, 150 µL of DMSO were added to each well to solubilize the formazan crystals and kept on a shaker for 10 to 15 min. The absorption of the formazan product was determined using a spectrophotometer at 570 nm. The percentage of cell viability was calculated using the following formula:
Cell viability = [OD sample/OD control] × 100,

3.9. Biocompatibility Analysis

The similar experiment was repeated as stated in Section 3.8. The only difference was cell lines. In this study, we used hMSC line.
Then, using the fluorescent staining approach, we employed a live/dead double staining kit to determine the viability of 293T cell line. The procedure was repeated until cancer cells were treated with different samples (10 µL at a concentration of 120 µg/mL) and incubated after treatment. After that, each well was incubated with the staining solution (4 g/mL) for 20 min at 37 °C. The images were taken using confocal laser scanning microscopy (CLSM) (535/617 nm and 361/497 nm excitation/emission wavelengths for PI and Hoechst 33,342, respectively).

3.10. Statistical Analysis

All biological assays were performed at three replicates, and results are presented in Mean ± SD. The significance level at p < 0.05 between the results was determined by applying One-way and two-way ANOVA.

4. Conclusions

Herein, we successfully reported the green synthesis of silver nanoparticles (OE-Ag NPs) by ecofriendly green processes using biological molecules of Olea europaea leaf extract. Green synthesized OE-Ag NPs were successfully characterized using different spectroscopic techniques. The results were demonstrated that synthesized OE-Ag NPs presented excellent log10 reduction in the growth of all the tested bacterial strains, which as statistically equivalent (p > 0.05) to the standard antibiotic drug. Moreover, they also demonstrated excellent cytotoxic efficacy against the MCF-7 carcinoma cells compared to plant lead extract and Com-Ag NPs. Green synthesized OE-Ag NPs appeared more biocompatible to 293 T and hMSC cells compared to Com-Ag NPs. Excellent biological results of the OE-Ag NPs might be attributed to the synergetic effect of NPs’ properties and the adsorbed secondary metabolites of plant leaf extract. Hence, this study suggests that synthesized OE-Ag NPs can be a potential contender for their various biological and nutraceutical applications. More study must be carried out to determine the dose-dependent biocompatibility in vitro as well as in vivo. Moreover, this study will open a new avenue to produce biocompatible nanoparticles with additional biological functionalities from the plants.

Author Contributions

Conceptualization, H.S. and S.A.K.; methodology, H.S. and S.A.K.; software, H.S.; validation, H.S. and S.A.K.; formal analysis, H.S.; investigation, H.S.; resources, H.S.; data curation, H.S., S.A.K. and I.A.; writing—original draft preparation, H.S., S.A.K. and I.A.; writing—review and editing, S.A.K., I.A., A.A.A., A.H.H. and A.E.A.-S.; visualization, H.S., S.A.K., I.A., A.A.A., A.H.H. and A.E.A.-S.; supervision, S.A.K.; project administration, S.A.K.; funding acquisition, A.A.A., A.H.H. and A.E.A.-S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by King Saud University, Riyadh, Saudi Arabia, grant number RG-1435-065. The APC was funded by RG-1435-065.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data are not publicly available.

Acknowledgments

The authors are very thankful to Fathi Ben Amar, from the olive institute of Sfax, Tunisia, for providing the leaves of Olea europaea used for this work. The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through research group no (RG-1435-065).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Magiorakos, A.P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-resistant, extensively drug resistant and pan drug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect 2012, 18, 268–281. [Google Scholar] [CrossRef] [Green Version]
  2. Singh, N.; Manchanda, V. Control of multidrug-resistant gram-negative bacteria in low-and middle-income countries—high impact interventions without much resources. Clin. Microbiol. Infect 2017, 23, 216–218. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Islam, S.; Aldstadt, J.; Aga, D. Global antimicrobial resistance: A complex and dire threat with few definite answers. Trop. Med. Int. Health 2019, 24, 658–662. [Google Scholar] [CrossRef] [PubMed]
  4. Nasrollahzadeh, M.; Sajadi, S.M.; Sajjadi, M.; Issaabadi, Z. An Introduction to Nanotechnology. Interface Sci. Technol. 2019, 28, 1–27. [Google Scholar]
  5. Khan, S.A.; Noreen, F.; Kanwal, S.; Iqbal, A.; Hussain, G. Green synthesis of ZnO and Cu-doped ZnO nanoparticles from leaf extracts of Abutilon indicum, Clerodendrum infortunatum, Clerodendrum inerme and investigation of their biological and photocatalytic activities. Mater. Sci. Eng. C 2018, 82, 46–59. [Google Scholar] [CrossRef]
  6. Foldbjerg, R.; Jiang, X.; Miclăuş, T.; Chen, C.; Autrup, H.; Beer, C. Silver nanoparticles–wolves in sheep’s clothing? Toxicol. Res. 2015, 4, 563–575. [Google Scholar] [CrossRef]
  7. Kumari, S.; Kumari, P.; Panda, P.K.; Patel, P.; Jha, E.; Mallick, M.A.; Suar, M.; Verma, S.K. Biocompatible biogenic silver nanoparticles interact with caspases on an atomic level to elicit apoptosis. Nanomedicine 2020, 15, 2119–2132. [Google Scholar]
  8. Kaliamurthi, S.; Selvaraj, G.; Cakmak, Z.E.; Cakmak, T. Production and characterization of spherical thermostable silver nanoparticles from Spirulina platensis (Cyanophyceae). Phycologia 2016, 55, 568–576. [Google Scholar] [CrossRef]
  9. Satyavani, K.; Ramanathan, T.; Gurudeeban, S. Plant mediated synthesis of biomedical silver nanoparticles by using leaf extract of Citrullus colocynthis. Res. J. Nanosci. Nanotechnol. 2011, 1, 95–101. [Google Scholar]
  10. Caro, C.; Castillo, P.M.; Klippstein, R.; Pozo, D.; Zaderenko, A.P. Silver nanoparticles: Sensing and imaging applications. In Silver Nanoparticles; Perez, D.P., Ed.; InTech: Rijeka, Croatia, 2010; Volume 95, pp. 201–224. [Google Scholar]
  11. Wijnhoven, S.W.P.; Peijnenburg, W.J.G.M.; Herberts, C.A.; Hagens, W.I.; Oomen, A.G.; Heugens, E.H.W.; Roszek, B.; Bisschops, J.; Gosens, I.; Van de Meent, D.; et al. Nano-silver: A review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3, 109–138. [Google Scholar] [CrossRef]
  12. Das, G.; Patra, J.K.; Shin, H.S. Biosynthesis, and potential effect of fern mediated biocompatible silver nanoparticles by cytotoxicity, antidiabetic, antioxidant and antibacterial, studies. Mater. Sci. Eng. C 2020, 114, 111011. [Google Scholar] [CrossRef] [PubMed]
  13. Tabera, J.; Guinda, A.; Ruiz-Rodriguez, A.; Senorans, J.F.; Ibanez, E.; Albi, T.; Reglero, G. Countercurrent supercritical fluid extraction and fractionation of high-added-value compounds from a hexane extract of olive leaves. J. Agric. Food Chem. 2004, 52, 4774–4779. [Google Scholar] [CrossRef]
  14. de Bock, M.; Thorstensen, E.B.; Derraik, J.G.; Henderson, H.V.; Hofman, P.L.; Cutfield, W.S. Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract. Mol. Nutr. Food Res. 2013, 57, 2079–2085. [Google Scholar] [CrossRef]
  15. Briante, R.; Patumi, M.; Terenziani, S.; Bismuto, E.; Febbraio, F.; Nucci, R. Olea europaea L. leaf extract and derivatives: Antioxidant properties. J. Agric. Food Chem. 2002, 50, 4934–4940. [Google Scholar] [CrossRef] [PubMed]
  16. Goulas, V.; Exarchou, V.; Troganis, A.N.; Psomiadou, E.; Fotsis, T.; Briasoulis, E.; Gerothanassis, I.P. Phytochemicals in olive-leaf extracts and their antiproliferative activity against cancer and endothelial cells. Mol. Nutr. Food Res. 2009, 53, 600–608. [Google Scholar] [CrossRef]
  17. Micol, V.; Caturla, N.; Pérez-Fons, L.; Mas, V.; Pérez, L.; Estepa, A. The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV). Antiviral Res. 2005, 66, 129–136. [Google Scholar] [CrossRef] [PubMed]
  18. Pereira, A.P.; Ferreira, I.C.F.R.; Marcelino, F.; Valentão, P.; Andrade, P.B.; Seabra, R.; Estevinho, L.; Bento, A.; Pereira, J.A. Phenolic compounds and antimicrobial activity of olive (Olea europaea L. Cv. Cobranc¸osa) leaves. Molecules 2007, 12, 1153–1162. [Google Scholar] [CrossRef] [PubMed]
  19. Bouaziz, M.; Sayadi, S. Isolation and evaluation of antioxidants from leaves of a Tunisian cultivar olive tree. Eur. J. Lipid. Sci. Tech. 2005, 107, 497–504. [Google Scholar] [CrossRef]
  20. Visioli, F.; Bellosta, S.; Galli, C. Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages. Life Sci. 1998, 62, 541–546. [Google Scholar] [CrossRef]
  21. Somova, L.I.; Shode, F.O.; Ramnanan, P.; Nadar, A. Antihypertensive, antiatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. J. Ethnopharmacol. 2003, 84, 299–305. [Google Scholar] [CrossRef]
  22. Wainstein, J.; Ganz, T.; Boaz, M.; Dayan, Y.B.; Dolev, E.; Kerem, Z.; Madar, Z. Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. J. Med. Food 2012, 15, 605–610. [Google Scholar] [CrossRef] [PubMed]
  23. Rashidipour, M.; Heydari, R. Biosynthesis of silver nanoparticles using extract of olive leaf: Synthesis and in vitro cytotoxic effect on MCF-7 cells. J. Nanostruct. Chem. 2014, 4, 112. [Google Scholar] [CrossRef] [Green Version]
  24. Khalil, M.M.H.; Ismail, E.H.; El-Baghdady, K.Z.; Mohamed, D. Green synthesis of silver nanoparticles using olive leaf extract and its antibacterial activity. Arab. J. Chem. 2014, 7, 1131–1139. [Google Scholar] [CrossRef] [Green Version]
  25. Hussain, A.; Alajmi, M.F.; Khan, M.A.; Pervez, S.A.; Ahmed, F.; Amir, S.; Husain, F.M.; Khan, M.S.; Shaik, G.M.; Hassan, I.; et al. Biosynthesized Silver Nanoparticle (AgNP) From Pandanus odorifer Leaf Extract Exhibits Anti-metastasis and Anti-biofilm Potentials. Front. Microbiol. 2019, 10, 8. [Google Scholar] [CrossRef] [Green Version]
  26. Alqahtani, M.A.; al Othman, M.R.; Mohammed, A.E. Bio Fabrication of Silver Nanoparticles with Antibacterial and Cytotoxic Abilities Using Lichens. Sci. Rep. 2020, 10, 16781. [Google Scholar] [CrossRef]
  27. Parthiban, E.; Manivannan, N.; Ramanibai, R.; Mathivanan, N. Green Synthesis of Silver-Nanoparticles from Annona Reticulata Leaves Aqueous Extract and Its Mosquito Larvicidal and Anti-Microbial Activity on Human Pathogens. Biotechnol. Rep. 2018, 20, e00297. [Google Scholar] [CrossRef]
  28. Ajitha, B.; Ashok Kumar Reddy, Y.; Sreedhara Reddy, P. Green Synthesis and Characterization of Silver Nanoparticles Using Lantana Camara Leaf Extract. Mater. Sci. Eng. C 2015, 49, 373–381. [Google Scholar] [CrossRef]
  29. Kasprzak, M.M.; Erxleben, A.; Ochocki, J. Properties and Applications of Flavonoid Metal Complexes. RSC Adv. 2015, 5, 45853–45877. [Google Scholar] [CrossRef]
  30. Khan, S.A.; Shahid, S.; Lee, C.-S.S. Green Synthesis of Gold and Silver Nanoparticles Using Leaf Extract of Clerodendrum Inerme; Characterization, Antimicrobial, and Antioxidant Activities. Biomolecules 2020, 10, 835. [Google Scholar] [CrossRef]
  31. Matteis, V.; de Rizzello, L.; Ingrosso, C.; Liatsi-Douvitsa, E.; Giorgi, M.L.; de Matteis, G.; de Rinaldi, R. Cultivar-Dependent Anticancer and Antibacterial Properties of Silver Nanoparticles Synthesized Using Leaves of Different Olea Europaea Trees. Nanomaterials 2019, 9, 1544. [Google Scholar] [CrossRef] [Green Version]
  32. Anandalakshmi, K.; Venugobal, J.; Ramasamy, V. Characterization of Silver Nanoparticles by Green Synthesis Method Using Pedalium Murex Leaf Extract and Their Antibacterial Activity. Appl. Nanosci. 2015, 6, 399–408. [Google Scholar] [CrossRef] [Green Version]
  33. Khan, M.; Shaik, M.R.; Adil, S.F.; Khan, S.T.; Al-Warthan, A.; Siddiqui, M.R.H.; Tahir, M.N.; Tremel, W. Plant Extracts as Green Reductants for the Synthesis of Silver Nanoparticles: Lessons from Chemical Synthesis. Dalton. Trans. 2018, 47, 11988–12010. [Google Scholar] [CrossRef] [PubMed]
  34. Roy, A.; Bulut, O.; Some, S.; Mandal, A.K.; Yilmaz, M.D. Green Synthesis of Silver Nanoparticles: Biomolecule-Nanoparticle Organizations Targeting Antimicrobial Activity. RSC Adv. 2019, 9, 2673–2702. [Google Scholar] [CrossRef] [Green Version]
  35. Hirpara, D.G.; Gajera, H.P. Green Synthesis and Antifungal Mechanism of Silver Nanoparticles Derived from Chitin- Induced Exometabolites of Trichoderma Interfusant. Appl. Organomet. Chem. 2020, 34, e5407. [Google Scholar] [CrossRef]
  36. Anandan, M.; Poorani, G.; Boomi, P.; Varunkumar, K.; Anand, K.; Chuturgoon, A.A. Green Synthesis of Anisotropic Silver Nanoparticles from the Aqueous Leaf Extract of Dodonaea Viscosa with Their Antibacterial and Anticancer Activities. Process. Biochem. 2019, 80, 80–88. [Google Scholar] [CrossRef]
  37. Yin, I.X.; Zhang, J.; Zhao, I.S.; Mei, M.L.; Li, Q.; Chu, C.H. The Antibacterial Mechanism of Silver Nanoparticles and Its Application in Dentistry. Int. J. Nanomed. 2020, 15, 2555. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Slavin, Y.N.; Asnis, J.; Häfeli, U.O.; Bach, H. Metal Nanoparticles: Understanding the Mechanisms behind Antibacterial Activity. J. Nanobiotechnol. 2017, 15, 65. [Google Scholar] [CrossRef] [PubMed]
  39. Pajerski, W.; Ochonska, D.; Brzychczy-Wloch, M.; Indyka, P.; Jarosz, M.; Golda-Cepa, M.; Sojka, Z.; Kotarba, A. Attachment Efficiency of Gold Nanoparticles by Gram-Positive and Gram-Negative Bacterial Strains Governed by Surface Charges. J. Nanopart. Res. 2019, 21, 186. [Google Scholar] [CrossRef] [Green Version]
  40. Ramalingam, B.; Parandhaman, T.; Das, S.K. Antibacterial Effects of Biosynthesized Silver Nanoparticles on Surface Ultrastructure and Nanomechanical Properties of Gram-Negative Bacteria Viz. Escherichia Coli and Pseudomonas Aeruginosa. ACS Appl. Mater. Interfaces 2016, 8, 4963–4976. [Google Scholar] [CrossRef] [PubMed]
  41. Kim, J.S.; Kuk, E.; Yu, K.N.; Kim, J.H.; Park, S.J.; Lee, H.J.; Kim, S.H.; Park, Y.K.; Park, Y.H.; Hwang, C.Y.; et al. Antimicrobial Effects of Silver Nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2007, 3, 95–101. [Google Scholar] [CrossRef]
  42. Chernousova, S.; Epple, M. Silver as Antibacterial Agent: Ion, Nanoparticle, and Metal. Angew. Chem. Int. Ed. 2013, 52, 1636–1653. [Google Scholar] [CrossRef] [PubMed]
  43. Carlson, C.; Hussain, S.M.; Schrand, A.M.; Braydich-Stolle, L.K.; Hess, K.L.; Jones, R.L.; Schlager, J.J. Unique Cellular Interaction of Silver Nanoparticles: Size-Dependent Generation of Reactive Oxygen Species. J. Phys. Chem. B 2008, 112, 13608–13619. [Google Scholar] [CrossRef] [PubMed]
  44. Rizwan, K.; Khan, S.A.; Ahmad, I.; Rasool, N.; Ibrahim, M.; Zubair, M.; Jaafar, H.Z.E.; Manea, R. A Comprehensive Review on Chemical and Pharmacological Potential of Viola Betonicifolia: A Plant with Multiple Benefits. Molecules 2019, 24, 3138. [Google Scholar] [CrossRef] [Green Version]
  45. Lfitat, A.; Zejli, H.; Bousraf, F.Z.; Bousselham, A.; el Atki, Y.; Gourch, A.; Lyoussi, B.; Abdellaoui, A. Comparative Assessment of Total Phenolics Content and in Vitro Antioxidant Capacity Variations of Macerated Leaf Extracts of Olea Europaea L. and Argania Spinosa (L.) Skeels. Mater. Today Proc. 2021, 45, 7271–7277. [Google Scholar] [CrossRef]
  46. Ghorbel, A.; Wedel, S.; Kallel, I.; Cavinato, M.; Sakavitsi, M.E.; Fakhfakh, J.; Halabalaki, M.; Jansen-Dürr, P.; Allouche, N. Extraction Yield Optimization of Oleaster (Olea Europaea Var. Sylvestris) Fruits Using Response Surface Methodology, LC/MS Profiling and Evaluation of Its Effects on Antioxidant Activity and Autophagy in HFF Cells. J. Food Meas. Charact. 2021, 15, 4946–4959. [Google Scholar] [CrossRef]
  47. Lins, P.G.; Marina Piccoli Pugine, S.; Scatolini, A.M.; de Melo, M.P. In Vitro Antioxidant Activity of Olive Leaf Extract (Olea Europaea L.) and Its Protective Effect on Oxidative Damage in Human Erythrocytes. Heliyon 2018, 4, e00805. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Bagchi, T.B.; Chattopadhyay, K.; Sivashankari, M.; Roy, S.; Kumar, A.; Biswas, T.; Pal, S. Effect of Different Processing Technologies on Phenolic Acids, Flavonoids and Other Antioxidants Content in Pigmented Rice. J. Cereal. Sci. 2021, 100, 103263. [Google Scholar] [CrossRef]
  49. Hernández, I.; Alegre, L.; van Breusegem, F.; Munné-Bosch, S. How Relevant Are Flavonoids as Antioxidants in Plants? Trends Plant Sci. 2009, 14, 125–132. [Google Scholar] [CrossRef] [PubMed]
  50. Pietta, P.G. Flavonoids as Antioxidants. J. Nat. Prod. 2000, 63, 1035–1042. [Google Scholar] [CrossRef] [PubMed]
  51. Kharat, S.N.; Mendhulkar, V.D. Synthesis, Characterization and Studies on Antioxidant Activity of Silver Nanoparticles Using Elephantopus Scaber Leaf Extract. Mater. Sci. Eng. C 2016, 62, 719–724. [Google Scholar] [CrossRef] [PubMed]
  52. Samsonowicz, M.; Regulska, E.; Kalinowska, M. Hydroxyflavone Metal Complexes-Molecular Structure, Antioxidant Activity and Biological Effects. Chem.-Biol. Interact 2017, 273, 245–256. [Google Scholar] [CrossRef]
  53. Marslin, G.; Siram, K.; Maqbool, Q.; Selvakesavan, R.K.; Kruszka, D.; Kachlicki, P.; Franklin, G. Secondary Metabolites in the Green Synthesis of Metallic Nanoparticles. Materials 2018, 11, 940. [Google Scholar] [CrossRef] [Green Version]
  54. Khan, A.U.; Khan, A.U.; Li, B.; Mahnashi, M.H.; Alyami, B.A.; Alqahtani, Y.S.; Alqarni, A.O.; Khan, Z.U.H.; Ullah, S.; Wasim, M.; et al. Biosynthesis of Silver Capped Magnesium Oxide Nanocomposite Using Olea Cuspidata Leaf Extract and Their Photocatalytic, Antioxidant and Antibacterial Activity. Photodiagnosis Photodyn. Ther. 2021, 33, 102153. [Google Scholar] [CrossRef] [PubMed]
  55. Mahendiran, D.; Subash, G.; Arumai Selvan, D.; Rehana, D.; Senthil Kumar, R.; Kalilur Rahiman, A. Biosynthesis of Zinc Oxide Nanoparticles Using Plant Extracts of Aloe Vera and Hibiscus Sabdariffa: Phytochemical, Antibacterial, Antioxidant and Anti-Proliferative Studies. BioNanoScience 2017, 7, 530–545. [Google Scholar] [CrossRef]
  56. Antoniou, C.; Hull, J. The Anti-Cancer Effect of Olea Europaea L. Products: A Review. Curr. Nutr. Rep. 2021, 10, 99–124. [Google Scholar] [CrossRef]
  57. Essafi Rhouma, H.; Trabelsi, N.; Chimento, A.; Benincasa, C.; Tamaalli, A.; Perri, E.; Zarrouk, M.; Pezzi, V. Olea Europaea L. Flowers as a New Promising Anticancer Natural Product: Phenolic Composition, Antiproliferative Activity and Apoptosis Induction. Nat. Prod. Res. 2019, 5, 1–4. [Google Scholar] [CrossRef] [PubMed]
  58. Zaïri, A.; Nouir, S.; Zarrouk, A.; Haddad, H.; Khélifa, A.; Achour, L. Phytochemical Profile, Cytotoxic, Antioxidant, and Allelopathic Potentials of Aqueous Leaf Extracts of Olea Europaea. Food Sci. Nutr. 2020, 8, 4805–4813. [Google Scholar] [CrossRef] [PubMed]
  59. Rezaeian, M.; Afjoul, H.; Shamloo, A.; Maleki, A.; Afjoul, N. Green Synthesis of Silica Nanoparticles from Olive Residue and Investigation of Their Anticancer Potential. Nanomedicine 2021, 16, 1581–1593. [Google Scholar] [CrossRef] [PubMed]
  60. Shahid, S.; Fatima, U.; Sajjad, R.; Khan, S.A. Bioinspired nanotheranostic agent: Zinc oxide; green synthesis and biomedical potential. Dig. J. Nanomater. Biostruct. 2019, 14, 1023–1031. [Google Scholar]
  61. Choi, K.H.; Nam, K.C.; Lee, S.Y.; Cho, G.; Jung, J.S.; Kim, H.J.; Park, B.J. Antioxidant Potential and Antibacterial Efficiency of Caffeic Acid-Functionalized ZnO Nanoparticles. Nanomaterials 2017, 7, 148. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. (a) Probable mechanism for the synthesis of OE-Ag NPs. (b,c) UV-Visible spectra of OE-Ag NPs and plant extract respectively. (d) FTIR analysis of plant extract and OE-Ag NPs.
Figure 1. (a) Probable mechanism for the synthesis of OE-Ag NPs. (b,c) UV-Visible spectra of OE-Ag NPs and plant extract respectively. (d) FTIR analysis of plant extract and OE-Ag NPs.
Ijms 22 12562 g001
Figure 2. (a) XRD, (b) TEM, (c) Size distribution, and (d) EDX analysis of green synthesized OE-Ag NPs.
Figure 2. (a) XRD, (b) TEM, (c) Size distribution, and (d) EDX analysis of green synthesized OE-Ag NPs.
Ijms 22 12562 g002
Figure 3. Antibacterial activity of green synthesized OE-Ag NPs in terms of log10 reduction in growth of all tested bacterial strains compared to plant leaves extract, Com-Ag NPs, and standard drug (**** and ns denote p < 0.0005, and p > 0.05, respectively).
Figure 3. Antibacterial activity of green synthesized OE-Ag NPs in terms of log10 reduction in growth of all tested bacterial strains compared to plant leaves extract, Com-Ag NPs, and standard drug (**** and ns denote p < 0.0005, and p > 0.05, respectively).
Ijms 22 12562 g003
Figure 4. Comparison between the cell wall structure and composition of both Gram-positive and Gram-negative bacterial strains [39].
Figure 4. Comparison between the cell wall structure and composition of both Gram-positive and Gram-negative bacterial strains [39].
Ijms 22 12562 g004
Figure 5. CLSM images of Live/dead bacteria. (a,c,e) control and (b,d,f) treated bacteria with green synthesized OE-Ag NPs.
Figure 5. CLSM images of Live/dead bacteria. (a,c,e) control and (b,d,f) treated bacteria with green synthesized OE-Ag NPs.
Ijms 22 12562 g005
Figure 6. Intracellular ROS generation investigation by CLSM in bacteria (S. aureus and P. aeruginosa) treated with green synthesized OE-Ag NPs in comparison to H2O2.
Figure 6. Intracellular ROS generation investigation by CLSM in bacteria (S. aureus and P. aeruginosa) treated with green synthesized OE-Ag NPs in comparison to H2O2.
Ijms 22 12562 g006
Figure 7. Antioxidant potential evolution in terms of percentage of DPPH free radical scavenging with green synthesized OE-Ag NPs compared to plant leaf extract, Com-Ag NPs, and standard antioxidant (ascorbic acid).
Figure 7. Antioxidant potential evolution in terms of percentage of DPPH free radical scavenging with green synthesized OE-Ag NPs compared to plant leaf extract, Com-Ag NPs, and standard antioxidant (ascorbic acid).
Ijms 22 12562 g007
Figure 8. (a) Cytotoxic propensity against MCF-7 carcinoma cells and (b) biocompatibility against hMSC cells after incubation for 24 h with OE-Ag NPs, plant leaf extract and Com-Ag NPs (**** p < 0.0001, *** p < 0.0005).
Figure 8. (a) Cytotoxic propensity against MCF-7 carcinoma cells and (b) biocompatibility against hMSC cells after incubation for 24 h with OE-Ag NPs, plant leaf extract and Com-Ag NPs (**** p < 0.0001, *** p < 0.0005).
Ijms 22 12562 g008
Figure 9. CLSM images of live/dead 293T cells. (a) Control (untreated) and treated with (b) plant extract, (c) Com-Ag NPs, and (d) OE-Ag NPs.
Figure 9. CLSM images of live/dead 293T cells. (a) Control (untreated) and treated with (b) plant extract, (c) Com-Ag NPs, and (d) OE-Ag NPs.
Ijms 22 12562 g009
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sellami, H.; Khan, S.A.; Ahmad, I.; Alarfaj, A.A.; Hirad, A.H.; Al-Sabri, A.E. Green Synthesis of Silver Nanoparticles Using Olea europaea Leaf Extract for Their Enhanced Antibacterial, Antioxidant, Cytotoxic and Biocompatibility Applications. Int. J. Mol. Sci. 2021, 22, 12562. https://doi.org/10.3390/ijms222212562

AMA Style

Sellami H, Khan SA, Ahmad I, Alarfaj AA, Hirad AH, Al-Sabri AE. Green Synthesis of Silver Nanoparticles Using Olea europaea Leaf Extract for Their Enhanced Antibacterial, Antioxidant, Cytotoxic and Biocompatibility Applications. International Journal of Molecular Sciences. 2021; 22(22):12562. https://doi.org/10.3390/ijms222212562

Chicago/Turabian Style

Sellami, Hanen, Shakeel Ahmad Khan, Ishaq Ahmad, Abdullah A. Alarfaj, Abdurahman H. Hirad, and Ahmed E. Al-Sabri. 2021. "Green Synthesis of Silver Nanoparticles Using Olea europaea Leaf Extract for Their Enhanced Antibacterial, Antioxidant, Cytotoxic and Biocompatibility Applications" International Journal of Molecular Sciences 22, no. 22: 12562. https://doi.org/10.3390/ijms222212562

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop